The long-term effects of respiratory viral infections such as COVID-19 are a major public health burden. Some estimates suggest over 65 million people around the world suffer from long COVID-19.

Duke-NUS researchers have identified that blocking specific proteins in immune cells can significantly reduce or reverse lung scarring. This discovery paves the way for novel treatments that could ...

"This work demonstrates the power of spatial transcriptomics combined with data science approaches in unraveling the molecular etiology of long COVID." The researchers note that the findings could ...

The most common type of lung fibrosis - scarring of the lungs -- is idiopathic, meaning of unknown cause. Researchers are urgently trying to find ways to prevent or slow idiopathic pulmonary fibrosis ...

At first glance, some people seem to have recovered from COVID-19. They no longer test positive and can return to work or school. But for many, the virus leaves behind a lasting impact—especially in ...

Pulmonary fibrosis is a deadly disease in which the lungs become thickened and scarred, gradually losing their ability to deliver oxygen to the body. Now, scientists at UC San Francisco have ...

he most common type of lung fibrosis — scarring of the lungs -- is idiopathic, meaning of unknown cause. Researchers are urgently trying to find ways to prevent or slow idiopathic pulmonary fibrosis ...

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Harish Narasimhan, University of Virginia (THE CONVERSATION) The long-term effects of ...